Arvinas (ARVN) Upgraded to Buy: What Does It Mean for the Stock?

4d ago, source: Zacks.com on MSN

This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the ...

Arvinas to Present at Upcoming Investor Conferences

3d ago, source:

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein ...

Arvinas Enters Deal With Novartis For License Of ARV-766, Sale Of AR-V7 Program; Stock Jumps

24d ago, source: Business Insider

(RTTNews) - Arvinas, Inc. (ARVN) has entered into an exclusive strategic license agreement with Novartis (NVS) for the worldwide development and commercialization of ARV-766, the company's second ...

Arvinas, Inc. (ARVN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

9d ago, source: Nasdaq

Arvinas, Inc. (ARVN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook ...

Arvinas Inc.

21d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer

11d ago, source: Stockhouse

NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...

Arvinas appoints new chief business officer

11d ago, source: Investing

NEW HAVEN, Conn. - Arvinas, Inc. (NASDAQ:ARVN), a biotechnology firm focused on developing therapies for serious diseases, announced today the promotion of Randy Teel, Ph.D., to the position of Chief ...

Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer

11d ago, source: Morningstar

NEW HAVEN, Conn., April 24, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation ...

Arvinas Inc.: Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer

10d ago, source:

Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced ...